Latest News of TRDA
Forecast: Analysts Think Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Business Prospects Have Improved Drastically
By Yahoo! Finance |
3 months ago
Analysts have significantly upgraded revenue estimates for Entrada Therapeutics (NASDAQ:TRDA), leading to a surge in stock price. Despite concerns of revenue decline in 2024, the company is expected t...
With 40% ownership, Entrada Therapeutics, Inc. (NASDAQ:TRDA) has piqued the interest of institutional investors
By Yahoo! Finance |
4 months ago
Five investors collectively own a majority stake of 55% in Entrada Therapeutics, Inc. Institutions hold the largest share at 40%, followed by hedge funds and insiders. This ownership structure influen...